Magnetic resonance angiography without contrast enhancement medium in bone and soft tissue tumors

Oncology Reports

Volumn 15, Issue 3, 2006, Pages 681-685

  Doi, Hideyuki ^a   Ono, Atsushi ^b   Kawai, Akira ^c   Morimoto, Yuki ^c   Kunisada, Toshiyuki ^a   Nakata, Eiji ^a   Ozaki, Toshifumi ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b Kosei Hospital   (Japan)

^c NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Angiography; Bone and soft tissue tumors; Contrast enhancement medium; Fresh blood imaging; Magnetic resonance imaging

Indexed keywords

CONTRAST MEDIUM;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE TUMOR; CHILD; DIFFERENTIAL DIAGNOSIS; FEMALE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOFT TISSUE TUMOR;

ADOLESCENT; ADULT; AGED; BONE NEOPLASMS; CHILD; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOFT TISSUE NEOPLASMS;

EID: 33645740501     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.3.681     Document Type: Article

References (22)

1. Winkler K, Bielack S, Delling G, Salzer-Kuntschik M, Kotz R, Greenshaw C, Jurgens H, Ritter J, Kusnierz-Glaz C, Erttmann R, et al: Effect of intraarterial versus intravenous cisplatin in addition to systemic doxorubicin, high-dose methotrexate, and ifosfamide on histologic tumor response in osteosarcoma (study COSS-86). Cancer 66: 1703-1710, 1990. (Pubitemid 20381203)
2. Rosen G: Neoadjuvant chemotherapy for osteogenic sarcoma: a model for the treatment of other highly malignant neoplasms. Recent Results Cancer Res 103: 148-157, 1986.
3. Rosen G: An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma. Cancer Treat Res 62: 49-54, 1993.
4. Bacci G, Ferrari S, Longhi A, Forni C, Bertoni F, Fabbri N, Zavatta M and Versari M: Neoadjuvant chemotherapy for high grade osteosarcoma of the extremities: long-term results for patients treated according to the Rizzoli IOR/OS-3b protocol. J Chemother 13: 93-99, 2001. (Pubitemid 32174727)
5. Fujii J, Ozaki T, Kawai A, Kunisada T, Sugihara S and Inoue H: Angiography for assessment of preoperative chemotherapy in musculoskeletal sarcomas. Clin Orthop 360: 197-206, 1999. (Pubitemid 29140950)
6. Owen RS CJ, Baum RA, Perloff LJ and Cope C: Magnetic resonance imaging of angiographycally occult runoff vessels in peripheral arterial occlusive disease. N Engl J Med 326: 1577-1581, 1992.
7. Ruehm SG, Goyen M, Barkhausen J, Kroger K, Bosk S, Ladd ME and Debatin JF: Rapid magnetic resonance angiography for detection of atherosclerosis. Lancet 357: 1086-1091, 2001. (Pubitemid 32322540)
8. Steffens JC, Link J, Muller-Hulsbeck S, Freund M, Brinkmann G and Heller M: Cardiac-gated two-dimensional phase-contrast MR angiography of lower extremity occlusive disease. Am J Roentgenol 169: 749-754, 1997.
9. Miyazaki M, Sugiura S, Tateishi F, Wada H, Kassai Y and Abe H: Non-contrast-enhanced MR angiography using 3D ECG-synchronized half-Fourier fast spin echo. J Magn Reson Imaging 12: 776-783, 2000.
10. Kita M, Mitani Y, Tanihata H, Kita K, Sato M, Takizawa O and Laub G: Moving-table reduced-dose gadolinium-enhanced three-dimensional magnetic resonance angiography: velocity-dependent method with three-phase gadolinium infusion. J Magn Reson Imaging 14: 319-328, 2001. (Pubitemid 32801067)
11. Urata J, Miyazaki M, Wada H, Nakaura T, Yamashita Y and Takahashi M: Clinical evaluation of aortic diseases using nonenhanced MRA with ECG-triggered 3D half-Fourier FSE. J Magn Reson Imaging 14: 113-119, 2001. (Pubitemid 32709469)
12. Ono A, Miyazaki M, Takata S, Nakai M, Tateishi A, Kuriyama M, Kawakami Y, Taniguchi T, Shibutani O, Watanabe N, et al: Evaluation of arterial occlusive diseases in lower extremity using non-contrast-enhanced MR arteriography with ECG triggered 3D half-Fourier FSE: initial experience at 0.5T: The 11th Meeting of the International Society for Magnetic Resonance in Medicine, Toronto, Abst, p1713, 2003.
13. Sherwood RJ, Rowley RB and Ward SC: Relative placement of the mandibular fossa in great apes and humans. J Hum Evol 43: 57-66, 2002. (Pubitemid 34842533)
14. Prince MR: Gadolinium-enhanced MR aortography. Radiology 191: 155-164, 1994.
15. Prince MR, Chabra SG, Watts R, Chen CZ, Winchester PA, Khilnani NM, Trost D, Bush HA, Kent KC and Wang Y: Contrast material travel times in patients undergoing peripheral MR angiography. Radiology 224: 55-61, 2002. (Pubitemid 34680375)
16. Maki JH, Prince MR, Londy FJ and Chenevert TL: The effects of time varying intravascular signal intensity and k-space acquisition order on three-dimensional MR angiography image quality. J Magn Reson Imaging 6: 642-651, 1996. (Pubitemid 126701436)
17. Miyazaki M, Ichinose N, Sugiura S, Kassai Y, Kanazawa H and Machida Y: A novel MR angiography technique: SPEED acquisition using half-Fourier RARE. J Magn Reson Imaging 8: 505-507, 1998. (Pubitemid 28150966)
18. Yokoyama K, Nitatori T, Inaoka S, Takahara T and Hachiya J: Non-contrast enhanced MR venography using 3D fresh blood imaging (FBI): initial experience. Radiat Med 19: 247-253, 2001. (Pubitemid 33111368)
19. Hudson TM, Enneking WF and Hawkins IF Jr: The value of angiography in planning surgical treatment of bone tumors. Radiology 138: 283-292, 1981. (Pubitemid 11179581)
20. Swan JS, Weber DM, Korosec FR, Grist TM and Heiner JP: Combined MRI and MRA for limb salvage planning. J Comput Assist Tomogr 17: 339-342, 1993. (Pubitemid 23086460)
21. Lang P, Grampp S, Vahlensieck M, Johnston JO, Honda G, Rosenau W, Matthay KK, Peterfy C, Higgins CB, Genant HK, et al : Primary bone tumors: value of MR angiography for preoperative planning and monitoring response to chemotherapy. Am J Roentgenol 165: 135-142, 1995.
22. Ono A, Takada S, Kawai A, Kawakami Y, Taniguchi T, Shibuya O, Sano M and Miyazaki M: MR arteriography for pelvic to thigh region by swap phase encoding method. Japan J Magn Reson Med 22: 81-90, 2002 (in Japanese).